Tirzepatide, a novel medication, is creating significant excitement in the scientific community as a potential treatment for both managing blood sugar and body composition . This dual-action drug works by targeting two distinct receptors, GLP-1 and GIP, leading to improved glycemic management and substantial fat loss in research studies . While ear